Streetbeat News

Stock Prices

LRCX

Shares of Lam Research Corporation (NASDAQ:LRCX) traded higher after Stifel analyst Brian Chin upgraded the company's rating from 'Hold' to 'Buy' and raised the price target from $505 to $725. The upgrade is based on the anticipated expansion of high bandwidth memory (HBM) capacity by Samsung in Q3, which is expected to benefit Lam Research due to its strong position in DRAM.

Portfolio Pulse from Priya Nigam

July 24, 2023 | 6:50 pm

AMC

CMCSA

CNK

IMAX

MAT

WBD

The movies 'Barbie' and 'Oppenheimer' set box office records over the weekend, with 'Barbie' grossing $155 million domestically and 'Oppenheimer' grossing $81 million. 'Barbie' was released by Warner Bros. Discovery and Mattel Inc, while 'Oppenheimer' was released by Comcast Corp's Universal unit. The strong performance of both movies could impact the stocks of Warner Bros. Discovery, Mattel Inc, Comcast Corp, and Imax Corporation, which played 'Oppenheimer' on its screens. AMC Entertainment Holdings and Cinemark Holdings also reported strong results following the weekend.

Portfolio Pulse from Chris Katje

July 24, 2023 | 6:48 pm

BKNG

A significant number of investors have taken a bearish stance on Booking Holdings (NASDAQ:BKNG), with 71% of detected trades showing bearish expectations. The whales have been targeting a price range from $1800.0 to $3800.0 for Booking Holdings over the last 3 months. The current price of BKNG is down -1.75% at $2871.96. Analysts from Wedbush, Morgan Stanley, JMP Securities, and Barclays have given varied price targets for the stock.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 6:45 pm

XXII

22nd Century Group has secured an additional $11.7 million in gross proceeds from a registered direct financing and announced the commencement of an estimated $15 million annualized cost reduction initiative. This news has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 6:41 pm

QNCX

Quince Therapeutics announced its plans to acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia in a stock-for-stock upfront exchange. Stockholders may receive up to $485 million in a potential earnout. This news has led to a decrease in Quince Therapeutics' share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 6:40 pm

HBAN

Huntington Bancshares Inc. (NASDAQ:HBAN) reported Q2 2023 earnings with revenues of $1.84 billion and EPS of $0.35, beating consensus. However, the company reduced its 2023 guidance for net interest income and noninterest income. Analysts from Raymond James, Stephens & Co., and RBC Capital Markets have given mixed reactions, with price target adjustments and rating changes.

Portfolio Pulse from Lekha Gupta

July 24, 2023 | 6:40 pm

CVKD

Cardenal Therapeutics has filed a Form S-1 for the resale of up to 8.85 million shares of common stock at $0.001 per share by the selling stockholders. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 6:38 pm

CTGO

Contango ORE has announced the pricing of a $30.4 million underwritten public offering of 1.6 million shares of its common stock at a price of $19 per share. Following the announcement, the company's shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 6:37 pm

HRTX

Heron Therapeutics has announced a cost reduction plan and a corporate restructuring that is expected to result in cash savings of approximately $75 million through 2025. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 6:37 pm

LTH

Mizuho analyst John J. Baumgartner has reiterated a Buy rating on Life Time Group Holdings, Inc. (NYSE:LTH), raising the price target to $25 from $23. The analyst expects an in-line Q2 EPS and potential upside to FY23 EBITDA guidance due to moderate macro headwinds and structural growth. LTH is also benefitting from overhead cost reductions and enhanced responsiveness and cost controls. The analyst is confident in LTH's same-store sales growth and reported net pricing realization. LTH shares are trading higher by 1.55% to $21.59.

Portfolio Pulse from Nabaparna Bhattacharya

July 24, 2023 | 6:34 pm